Report #2843538

Received Jun 2, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: CA
Recovered: Unknown
Vaccinated: Apr 26, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	UNK	945665	—

Symptoms (2)

Joint swellingPeripheral swelling

Symptom narrative

Swollen Joints; Swollen Feet; Swollen Fingers; Initial report received on 06-May-2025. A consumer reported that she, a female (age, race, and ethnicity not reported) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and experienced swollen feet, fingers, and joints. Medical history included psoriatic arthritis. No concomitant medications were reported at the time of vaccination. On 26-Apr-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (Lot # 945665, expiration date, NDC #, route, and site not available). On an unknown date, a few days after receiving HEPLISAV-B, she experienced swelling in the feet, fingers, and joints. No additional information was reported. Company Comment: he company assessed the events as non-serious.; Sender's Comments: he company assessed the events as non-serious.

Current illness

Psoriatic arthritis (Comorbidity)